Oryzon Genomics S.A. (BME:ORY)
Spain
· Delayed Price · Currency is EUR 2.790
-0.022 (-0.78%)
Apr 28, 2026, 5:35 PM CET
Oryzon Genomics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 28.35 | 5.62 | 12.26 | 21.32 | 28.72 | Upgrade
|
| Short-Term Investments | 0.01 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 28.37 | 5.62 | 12.26 | 21.32 | 28.72 | Upgrade
|
| Cash Growth | 404.91% | -54.16% | -42.50% | -25.79% | -27.47% | Upgrade
|
| Other Receivables | 2.24 | 3.11 | 2.01 | 3.84 | 3.78 | Upgrade
|
| Receivables | 2.24 | 3.11 | 2.01 | 3.84 | 3.78 | Upgrade
|
| Inventory | 0 | 0 | 0.01 | 0.01 | 0.1 | Upgrade
|
| Other Current Assets | 0.06 | 0.02 | 0 | - | - | Upgrade
|
| Total Current Assets | 30.67 | 8.75 | 14.28 | 25.16 | 32.61 | Upgrade
|
| Property, Plant & Equipment | 0.38 | 0.36 | 0.48 | 0.61 | 0.68 | Upgrade
|
| Other Intangible Assets | 0.19 | 0.22 | 0.38 | 0.52 | 0.63 | Upgrade
|
| Long-Term Deferred Tax Assets | 4.13 | 2.39 | 2.22 | 2.05 | 1.81 | Upgrade
|
| Long-Term Deferred Charges | 109.03 | 98 | 89.51 | 75.32 | 59.62 | Upgrade
|
| Other Long-Term Assets | 0.13 | 0.13 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Total Assets | 144.52 | 109.85 | 106.9 | 103.7 | 95.38 | Upgrade
|
| Accounts Payable | 2.75 | 2.13 | 3.41 | 5.06 | 2.91 | Upgrade
|
| Accrued Expenses | 0.64 | 0.58 | 0.6 | 0.54 | 1.24 | Upgrade
|
| Current Portion of Long-Term Debt | 10.98 | 8.74 | 11.92 | 12.17 | 4.17 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
| Other Current Liabilities | 1.37 | 0.27 | 0.46 | 0.93 | 0.35 | Upgrade
|
| Total Current Liabilities | 15.77 | 11.74 | 16.41 | 18.73 | 8.67 | Upgrade
|
| Long-Term Debt | 6.75 | 7.42 | 6.28 | 10.27 | 13.35 | Upgrade
|
| Long-Term Leases | 0.01 | 0.03 | 0.06 | 0.08 | - | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.09 | - | - | 0.28 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.13 | 2.39 | 2.22 | 2.05 | 1.81 | Upgrade
|
| Other Long-Term Liabilities | 0.02 | - | 0.15 | - | - | Upgrade
|
| Total Liabilities | 26.68 | 21.67 | 25.13 | 31.13 | 24.12 | Upgrade
|
| Common Stock | 3.99 | 3.29 | 3.06 | 2.78 | 2.65 | Upgrade
|
| Additional Paid-In Capital | 132.16 | 100.71 | 92.38 | 79.69 | 73.96 | Upgrade
|
| Retained Earnings | -20.76 | -18.16 | -15.62 | -12.27 | -8.04 | Upgrade
|
| Treasury Stock | -5.81 | -2.03 | -0.55 | -0.62 | -0.69 | Upgrade
|
| Comprehensive Income & Other | 8.27 | 4.36 | 2.51 | 3 | 3.38 | Upgrade
|
| Shareholders' Equity | 117.85 | 88.17 | 81.77 | 72.57 | 71.26 | Upgrade
|
| Total Liabilities & Equity | 144.52 | 109.85 | 106.9 | 103.7 | 95.38 | Upgrade
|
| Total Debt | 17.76 | 16.21 | 18.27 | 22.54 | 17.52 | Upgrade
|
| Net Cash (Debt) | 10.61 | -10.59 | -6.02 | -1.22 | 11.2 | Upgrade
|
| Net Cash Growth | - | - | - | - | -57.02% | Upgrade
|
| Net Cash Per Share | 0.14 | -0.16 | -0.10 | -0.02 | 0.21 | Upgrade
|
| Filing Date Shares Outstanding | 77.51 | 64.75 | 60.88 | 55.29 | 52.76 | Upgrade
|
| Total Common Shares Outstanding | 77.51 | 64.75 | 60.88 | 55.29 | 52.76 | Upgrade
|
| Working Capital | 14.9 | -2.99 | -2.14 | 6.43 | 23.93 | Upgrade
|
| Book Value Per Share | 1.52 | 1.36 | 1.34 | 1.31 | 1.35 | Upgrade
|
| Tangible Book Value | 117.66 | 87.95 | 81.39 | 72.05 | 70.63 | Upgrade
|
| Tangible Book Value Per Share | 1.52 | 1.36 | 1.34 | 1.30 | 1.34 | Upgrade
|
| Machinery | 1.66 | 1.62 | 1.62 | 1.64 | 1.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.